Optimeos Life Sciences, a startup founded by two Princeton University faculty members, has reached agreements with six pharmaceutical companies to develop therapeutics using a Princeton-developed drug delivery technology. The collaborations have the potential to improve the effectiveness of medications for the treatment of diseases, ranging from cancer to diabetes.
As another sign that entrepreneurship is booming at Princeton University, the Slavin Family Foundation awarded undergraduates Matthew Marquardt, a chemistry major in the Class of 2021, and Rohan Shah, a molecular biology major in the Class of 2020, with Slavin Fellowships for their work in entrepreneurship on campus and beyond. They are among 26 global recipients of the Slavin Fellowships.
In front of a collection of industry representatives, Princeton faculty, staff and fellow students in early June, a new sub-team of the Princeton Entrepreneurship Club named Alimtas BioVentures capped a year of unprecedented entrepreneurial work at the University. Alimtas, a self-managed team of Princeton undergrads, formed a multidisciplinary team to perform due diligence and develop a fundraising pitch deck for a technology developed by Princeton faculty.
By Pooja Makhijani, Princeton Institute for International and Regional Studies
